Drug-loaded erythrocytes: on the road toward marketing approval

References

• PierigeFSerafiniSRossiLCell-based drug deliveryAdv Drug Deliv Rev200860228629517997501
   PubMed Web of Science ®Google Scholar
• PatelRPPatelMJPatelNAAn overview of resealed erythrocyte drug deliveryJ Pharm Res20092610081012
   Google Scholar
• MillanCGMarineroMLCastanedaAZDrug, enzyme and peptide delivery using erythrocytes as carriersJ Control Release2004951274915013230
   PubMed Web of Science ®Google Scholar
• GothoskarAVResealed erythrocytes: a reviewPharmaceutical Technology [serial on the internet]2004140158 Available from: http://www.pharmtech.comAccessed December 6, 2015
   Google Scholar
• HarisaGEIbrahimMFAlanaziFKApplication and safety of erythrocytes as a novel drug delivery systemAsian J Biochem20116309321
   Google Scholar
• MuzykantovVRDrug delivery by red blood cells: vascular carriers designed by mother natureExpert Opin Drug Deliv20107440342720192900
   PubMed Web of Science ®Google Scholar
• GutierrezMCColino GandarillasCISayalero MarineroMLCell-based drug-delivery platformsTher Deliv201231254122833931
   PubMedGoogle Scholar
• DomenechCThomasXChabaudSl-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005-01 randomized trialBr J Haematol2011153586521332712
   PubMed Web of Science ®Google Scholar
• Tirupathi RaoKSuria PrabhaKMuthu PrasannaPResealed erythrocytes: as a specified tool in novel drug delivery carrier systemRes J Pharm Biol Chem Sci201124496512
   Google Scholar
• KitaoTHattoriKErythrocyte entrapment of daunomycin by amphotericin B without hemolysisCancer Res1980404135113537357561
   PubMed Web of Science ®Google Scholar
• LiLHHensenMLZhaoYLElectrofusion between heterogeneous-sized mammalian cells in a pellet: potential applications in drug delivery and hybridoma formationBiophys J19967114794868804630
   PubMed Web of Science ®Google Scholar
• NicolauCGersondeKIncorporation of inositol hexaphosphate into intact red blood cells. I. Fusion of effector-containing lipid vesicles with erythrocytesNaturwissenschaften19796611563566514370
   PubMed Web of Science ®Google Scholar
• GinnFLHochsteinPTrumpBFMembrane alterations in hemolysis: internalization of plasmalemma induced by primaquineScience196916438818438455767788
   PubMed Web of Science ®Google Scholar
• HarisaGEIbrahimMFAlanaziFKCharacterization of human erythrocytes as potential carrier for pravastatin: an in vitro studyInt J Med Sci20118322223021448309
   PubMed Web of Science ®Google Scholar
• TalwarNJainNKErythrocyte based delivery system of primaquine: in vitro characterizationJ Microencapsul1992933573641403486
   PubMed Web of Science ®Google Scholar
• SchrierSLJungaIEntry and distribution of chlorpromazine and vinblastine into human erythrocytes during endocytosisProc Soc Exp Biol Med198116821591677348300
   PubMed Web of Science ®Google Scholar
• GreenwaltTJLauFOSwierkEMStudies of erythrocyte membrane loss produced by amphipathic drugs and in vitro storageBr J Haematol1978394551557698128
   PubMed Web of Science ®Google Scholar
• KwonYMChungHSMoonCL-Asparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia (ALL)J Control Release2009139318218919577600
   PubMed Web of Science ®Google Scholar
• HeHYeJWangYCell-penetrating peptides meditated encapsulation of protein therapeutics into intact red blood cells and its applicationJ Control Release201417612313224374002
   PubMed Web of Science ®Google Scholar
• FrancoRSWeinerMWagnerKIncorporation of inositol hexaphosphate into red blood cells mediated by dimethyl sulfoxideLife Sci19833224276327686855471
   PubMed Web of Science ®Google Scholar
• FrancoRBarkerRMayfieldGThe in vivo survival of human red cells with low oxygen affinity prepared by the osmotic pulse method of inositol hexaphosphate incorporationTransfusion19903031962002315992
   PubMed Web of Science ®Google Scholar
• MoscaAPaleariRRussoVIHP entrapment into human erythrocytes: comparison between hypotonic dialysis and DMSO osmotic pulseAdv Exp Med Biol199232619261295306
   PubMedGoogle Scholar
• TsongTYElectroporation of cell membranesBiophys J19916022973061912274
   PubMed Web of Science ®Google Scholar
• TsongTYKinositaKJrUse of voltage pulses for the pore opening and drug loading, and the subsequent resealing of red blood cellsBibl Haematol1985511081144004753
   PubMedGoogle Scholar
• MitchellDHJamesGTKruseCABioactivity of electric field-pulsed human recombinant interleukin-2 and its encapsulation into erythrocyte carriersBiotechnol Appl Biochem19901232642752360992
   PubMed Web of Science ®Google Scholar
• LizanoCSanzSLuqueJIn vitro study of alcohol dehydrogenase and acetaldehyde dehydrogenase encapsulated into human erythrocytes by an electroporation procedureBiochim Biophys Acta1998142523283369795248
   PubMed Web of Science ®Google Scholar
• DongQJinWMonitoring diclofenac sodium in single human erythrocytes introduced by electroporation using capillary zone electrophoresis with electrochemical detectionElectrophoresis200122132786279211545409
   PubMed Web of Science ®Google Scholar
• DzekunovSMWangSHHansonDHinventorsMaxcyte Inc., assigneeApparatus and method for electroporation of biological samplesUnited States patent US7186559200736
   Google Scholar
• NicolauCBruggemannUMouneimneYConrad RouxEinventorsCbr Laboratories Inc., assigneeMethod and apparatus for encapsulation of biologically-active substancesPatent EP14669682006104
   Google Scholar
• BruggemannURouxECHannigJLow-oxygen-affinity red cells produced in a large-volume, continuous-flow electroporation systemTransfusion19953564784867770898
   PubMed Web of Science ®Google Scholar
• RechsteinerMCUptake of proteins by red blood cellsExp Cell Res19759324874921098917
   PubMed Web of Science ®Google Scholar
• HamidiMZarrinAHForoozeshMPreparation and in vitro evaluation of carrier erythrocytes for RES-targeted delivery of interferon-alpha 2bInt J Pharm20073411–212513317512685
   PubMedGoogle Scholar
• HamidiMTajerzadehHDehpourARIn vitro characterization of human intact erythrocytes loaded by enalaprilatDrug Deliv20018422323011757780
   PubMed Web of Science ®Google Scholar
• MagnaniMRossiLD’ascenzoMErythrocyte engineering for drug delivery and targetingBiotechnol Appl Biochem199828pt 1169693082
   PubMedGoogle Scholar
• RossiLSerafiniSPierigéFErythrocytes as a controlled drug delivery system: clinical evidencesJ Control Release20061162e43e4517718962
   PubMed Web of Science ®Google Scholar
• BiagiottiSPaolettiMFFraternaleADrug delivery by red blood cellsIUBMB Life201163862163121766411
   PubMed Web of Science ®Google Scholar
• BaxBEBainMDFairbanksLDIn vitro and in vivo studies with human carrier erythrocytes loaded with polyethylene glycol-conjugated and native adenosine deaminaseBr J Haematol2000109354955410886203
   PubMed Web of Science ®Google Scholar
• BaxBEBainMDFairbanksLDA 9-yr evaluation of carrier erythrocyte encapsulated adenosine deaminase (ADA) therapy in a patient with adult-type ADA deficiencyEur J Haematol200779433834817680812
   PubMed Web of Science ®Google Scholar
• GodfrinYBaxBEEnzyme bioreactors as drugsDrugs Future2012374263272
   Web of Science ®Google Scholar
• BourgeauxVHequetOCampionYInositol hexaphosphate-loaded red blood cells prevent in vitro sicklingTransfusion201050102176218420456710
   PubMed Web of Science ®Google Scholar
• BanzACremelMRembertAIn situ targeting of dendritic cells by antigen-loaded red blood cells: a novel approach to cancer immunotherapyVaccine201028172965297220188177
   PubMed Web of Science ®Google Scholar
• RoparsCNicolauCChassaigneMinventorsCNRS, Centre Hospitalier Regional De Tours, Studiengesellschaft Kohle mbH, assigneesProcédé et dispositif pour l’encapsulation dans les érythrocytes d’au moins une substance à activité biologique, notamment des effecteurs allostériques de l’hémoglobine et érythrocytes ainsi obtenus [Process and device for the encapsulation in erythrocytes of at least one biologically active substance, in particular hemoglobin allosteric effectors, and erythrocytes so obtained]Patent EP01013411986115 French
   Google Scholar
• GodfrinYinventorErytech Pharma, assigneeLysis/resealing process and device for incorporating an active ingredient, in particular asparaginase or inositol hexaphosphate, in erythrocytesPatent WO20060162472006216
   Google Scholar
• DarghouthDKoehlBHeilierJFAlterations of red blood cell metabolome in overhydrated hereditary stomatocytosisHaematologica201196121861186521859730
   PubMed Web of Science ®Google Scholar
• BernhardtILloryJCRed Cell Membrane Transport in Health and DiseaseBerlinSpringer-Verlag2003
   Google Scholar
• MagnaniMRossiLBagiottiSBianchiMinventorsDrug delivery systemsUnited States patent USWO2010145849 A320111215
   Google Scholar
• BiagiottiSRossiLBianchiMImmunophilin-loaded erythrocytes as a new delivery strategy for immunosuppressive drugsJ Control Release2011154330631321640771
   PubMed Web of Science ®Google Scholar
• ForoozeshMHamidiMZarrinAPreparation and in-vitro characterization of tramadol-loaded carrier erythrocytes for long-term intravenous deliveryJ Pharm Pharmacol201163332233221749379
   PubMed Web of Science ®Google Scholar
• TonettiMAstroffABSatterfieldWPharmacokinetic properties of doxorubicin encapsulated in glutaraldehyde-treated canine erythrocytesAm J Vet Res19915210163016351767983
   PubMed Web of Science ®Google Scholar
• TonettiMAstroffBSatterfieldWConstruction and characterization of adriamycin-loaded canine red blood cells as a potential slow delivery systemBiotechnol Appl Biochem19901266216292128736
   PubMed Web of Science ®Google Scholar
• DeLoachJRBartonCGlutaraldehyde-treated carrier erythrocytes for organ targeting of methotrexate in dogsAm J Vet Res19814211197119746802043
   PubMed Web of Science ®Google Scholar
• BaskurtOKThe role of spleen in suppressing the rheological alterations in circulating bloodClin Hemorheol Microcirc199920318118810463842
   PubMed Web of Science ®Google Scholar
• LuoRMutukumaraswamySVenkatramanSSEngineering of erythrocyte-based drug carriers: control of protein release and bioactivityJ Mater Sci Mater Med2012231637122095447
   PubMed Web of Science ®Google Scholar
• ZocchiEGuidaLBenattiUHepatic or splenic targeting of carrier erythrocytes: a murine modelBiotechnol Appl Biochem1987954234343675876
   PubMed Web of Science ®Google Scholar
• BanzACremelMMouvantATumor growth control using red blood cells as the antigen delivery system and poly(I: C)J Immunother201235540941722576346
   PubMed Web of Science ®Google Scholar
• SprandelUWayJLErythrocytes as Drug Carriers in MedicineNew York, NYPlenum Press1996
   Google Scholar
• ChiarantiniLRossiLFraternaleAModulated red blood cell survival by membrane protein clusteringMol Cell Biochem1995144153597791745
   PubMed Web of Science ®Google Scholar
• MagnaniMRossiLBrandiGTargeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: in vitro and in vivo studiesProc Natl Acad Sci U S A19928914647764811631145
   PubMed Web of Science ®Google Scholar
• MagnaniMCasabiancaAFraternaleASynthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infectionProc Natl Acad Sci U S A1996939440344088633079
   PubMed Web of Science ®Google Scholar
• MagnaniMMagnaniMErythrocyte Engineering for Drug Delivery and TargetingNew York, NYSpringer, Kluwer Academic/Plenum Publishers2003
   Google Scholar
• HamidiMZareiNZarrinAHPreparation and in vitro characterization of carrier erythrocytes for vaccine deliveryInt J Pharm20073381–2707817317049
   PubMedGoogle Scholar
• PolvaniCGaspariniABenattiUMurine red blood cells as efficient carriers of three bacterial antigens for the production of specific and neutralizing antibodiesBiotechnol Appl Biochem19911433473561777119
   PubMed Web of Science ®Google Scholar
• MagnaniMChiarantiniLVittoriaERed blood cells as an antigen-delivery systemBiotechnol Appl Biochem19921621881941457052
   PubMed Web of Science ®Google Scholar
• CremelMGuerinNHorandFRed blood cells as innovative antigen carrier to induce specific immune toleranceInt J Pharm20134431–2394923305866
   PubMedGoogle Scholar
• GodfrinYBertrandYL-asparaginase introduced into erythrocytes for the treatment of leukemia (ALL)Oncol News20061124
   Google Scholar
• MollërHOldenhofCThe active pharmaceutical ingredients starting material (APISM) and other materials in API manufactureDrug Inf J199933755761
   Google Scholar
• European Medicines Agency (EMA)Reflection paper on clinical aspects related to tissue engineered products [report]Report of Committee for Advanced Therapies (Draft)London2012Report No 139870
   Google Scholar
• BurgerSRDesign and operation of a current good manufacturing practices cell-engineering laboratoryCytotherapy20002211112212042048
   PubMed Web of Science ®Google Scholar
• Casaroli-MaranoRPTaberaJVilarrodonaARegulatory issues in cell-based therapy for clinical purposesDev Ophthalmol20145318920024732772
   PubMedGoogle Scholar
• U.S. Department of Health and Human Services Food and Drug AdministrationGuidance for Industry and FDA Staff: Minimal Manipulation of Structural Tissue Jurisdictional Update [guideline]Silver Spring, MDU.S. Department of Health and Human Services Food and Drug Administration2006
   Google Scholar
• National Institute of Health Science (NIHS)Guideline for Quality and Safety Assurance of Pharmaceuticals and Medical devices Based on Human Autologous Cells or TissueResearch Triangle Park, NCNational Institute of Health Science (NIHS)2008 guideline in Japanese
   Google Scholar
• SparrowRLSranAHealeyGIn vitro measures of membrane changes reveal differences between red blood cells stored in saline-adenine-glucose-mannitol and AS-1 additive solutions: a paired studyTransfusion201454356056823869602
   PubMed Web of Science ®Google Scholar
• Sowemimo-CokerSOEvaluation of an experimental filter designed for improving the quality of red blood cells (RBCs) during storage by simultaneously removing white blood cells and immunomodulators and improving RBC viscoelasticity and Band 3 proteinsTransfusion201454359260123834280
   PubMed Web of Science ®Google Scholar
• BrandenbergerRBurgerSCampbellACell therapy bioprocessing. Integrating process and product development for the next generation of biotherapeuticsBioProcess Int20119S13037
   Google Scholar
• BessisMMohandasNFeoCAutomated ektacytometry: a new method of measuring red cell deformability and red cell indicesBlood Cells1980633153277397390
   PubMedGoogle Scholar
• LamarreYBourgeauxVPichonAEffect of inositol hexaphosphate-loaded red blood cells (RBCs) on the rheology of sickle RBCsTransfusion201353362763622804873
   PubMed Web of Science ®Google Scholar
• DacieJVLondMBVaughanJMThe fragility of the red blood cells: its measurement and significanceJ Pathol Bacteriol1938462341356
   Google Scholar
• GuarnoneRCentenaraEBarosiGPerformance characteristics of Hemox-Analyzer for assessment of the hemoglobin dissociation curveHaematologica19958054264308566883
   PubMed Web of Science ®Google Scholar
• MoroffGSohmerPRButtonLNProposed standardization of methods for determining the 24-hour survival of stored red cellsTransfusion19842421091146710582
   PubMed Web of Science ®Google Scholar
• International Committee for Standardization in HaematologyRecommended method for radioisotope red-cell survival studiesBr J Haematol19804546596667426443
   PubMed Web of Science ®Google Scholar
• ValeriCRMacGregorHGiorgioAComparison of radioisotope methods and a nonradioisotope method to measure the RBC volume and RBC survival in the baboonTransfusion200343101366137314507266
   PubMed Web of Science ®Google Scholar
• ZeilerTMullerJKretschmerVFlow cytometric determination of survival time and 24-hour recovery of transfused Red blood cellsTransfus Med Hemother2003301419
   Web of Science ®Google Scholar
• BoucherLChassaigneMRoparsCInternalization and distribution of inositol hexakisphosphate in red blood cellsBiotechnol Appl Biochem199624pt 173788756396
   PubMedGoogle Scholar
• Hunault-BergerMLeguayTHuguetFA Phase 2 study of L-asparaginase encapsulated in erythrocytes in elderly patients with Philadelphia chromosome negative acute lymphoblastic leukemia: the GRASPALL/GRAALL-SA2-2008 studyAm J Hematol201590981181826094614
   PubMed Web of Science ®Google Scholar
• BourgeauxVAufradetECampionYEfficacy of homologous inositol hexaphosphate-loaded red blood cells in sickle transgenic miceBr J Haematol201215735736922404654
   PubMed Web of Science ®Google Scholar
• RossiLSerafiniSCeneriniLErythrocyte-mediated delivery of dexamethasone in patients with chronic obstructive pulmonary diseaseBiotechnol Appl Biochem200133pt 2858911277860
   PubMed Web of Science ®Google Scholar
• RossiLCastroMD’OrioFLow doses of dexamethasone constantly delivered by autologous erythrocytes slow the progression of lung disease in cystic fibrosis patientsBlood Cells Mol Dis2004331576315223012
   PubMed Web of Science ®Google Scholar
• CastroMRossiLPapadatouBLong-term treatment with autologous red blood cells loaded with dexamethasone 21-phosphate in pediatric patients affected by steroid-dependent Crohn diseaseJ Pediatr Gastroenterol Nutr200744442342617414137
   PubMed Web of Science ®Google Scholar
• MenottaMBiagiottiSBianchiMDexamethasone partially rescues ataxia telangiectasia-mutated (ATM) deficiency in ataxia telangiectasia by promoting a shortened protein variant retaining kinase activityJ Biol Chem201228749413524136323055520
   PubMed Web of Science ®Google Scholar
• ChessaLLeuzziVPlebaniAIntra-erythrocyte infusion of dexamethasone reduces neurological symptoms in ataxia teleangiectasia patients: results of a phase 2 trialOrphanet J Rare Dis201491524405665
   PubMedGoogle Scholar
• LeuzziVMicheliRD’AgnanoDPositive effect of erythrocyte-delivered dexamethasone in ataxia-telangiectasiaNeurol Neuroimmunol Neuroinflamm201523e9825884015
   PubMed Web of Science ®Google Scholar